Duke University is working on developing HIV vaccines. The idea behind the vaccine is that it owuld bind to hte GP-120 glycoportein on HIV's envelope.
The paper refers to a previous trial in which Thailand developed a vaccine that was "partially effective"
I think this article is interesting in that it mentions the specific receptor that vaccine is expected to bind to. But it doesn't elaborate on the mechanism of action after binding and how it work. Also, the "partially effective" vaccine form Thailand sounds kind of sketchy - I'm curious to learn how it was partially effective and how the researchers tested it.
Overall, this article proposes a good idea, hopefully there will be a HIV vaccine in the future.